It means that as a standalone oral therapy at the tested doses, it did not produce the magnitude of weight loss that pharmaceutical companies require for commercial viability
While preliminary findings suggest the safety of 5-amino-1MQ, clinical data is still lacking, and continuous scrutiny is essential for researchers to understand its effects across diverse demographic groups
For randomised clinical trials, the Jadad scale ( To complement the Jadad score, the Cochrane Risk of Bias Tool (RoB 2) (Sterne et al., 2019) was also used for RCTs to provide a domain-based qualitative evaluation, assessing risks related to selection, performance, detection, attrition, and reporting
It is not a weight-loss drug on its own, and Dr
Its primarily in the Liver, Yes - but there are much smaller stores elsewhere for " local" processing...these are not part of the digestive process
Journal of Orthopaedic Research , 24(7), 1421-1432.